| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |